See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2021_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 166,065,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 52,660,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,077,000 |
| 3 | remainder_Assets | 32,388,000 |
| 4 | LiabilitiesCurrent | 38,085,000 |
| 5 | LiabilitiesNoncurrent | 29,094,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 34,177,751 |
| 8 | SellingGeneralAndAdministrativeExpense | 80,197,929 |
| 9 | ResearchAndDevelopmentExpense | 30,419,170 |
| 10 | remainder_Expenses | 22,311,267 |
| 11 | remainder_Revenues | 176,895,067 |
| 12 | remainder_NetIncome | 173,656 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 253,190,000 |
| 1 | Liabilities | 67,179,000 |
| 2 | Expenses | 167,106,117 |
| 3 | Revenues | 176,895,067 |
| 4 | StockholdersEquity | 186,011,000 |
| 5 | NetIncome | 9,962,606 |
| 6 | ComprehensiveNetIncome | 9,962,606 |
| 7 | BaseVar | 332,271,920 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.59 |
| 9 | EconomicCapitalRatio | 3.42 |
Edgar->Model Mapping
Feature Distribution
Change over Time
